The global cell expansion market size is predicted to value USD 42.19 billion by 2026 from USD 17.92 billion in 2021, growing at a CAGR of 18.68% during the forecast period.
Expansion of stem cells is a pre-requisite for stem cells or even fully differentiated cell populations to be genuinely beneficial in their utility as drug screening tools or even for core research purposes. Cell Expansion is basically done by cloning, which implies the derivation of the state of cells or substances from the same cell or multiple varied sources. The required environment for stem cell expansion is maintained by various media, reagents, and supplements. It may also involve the participation of healthy feeder populations or conditioned components taken off feeder cells.
MARKET DRIVERS:
Y-O-Y growth in the incidence of chronic ailments, increasing research and development activities, and favorable government initiatives for regenerative medicine accelerates the global cell expansion market growth.
The prevalence of infectious and chronic diseases is significantly growing. Cardiovascular diseases (CVDs) are the leading cause of death rate globally. As per the WHO, around 17.9 million people died due to CVDs in 2016, depicting 31% of global death. Companies operating in this market are investing significant amounts in R&D to develop better solutions.
The global regenerative medicine market is forecasted to grow 23.24% between 2020 to 2025, which is also expected to accelerate the market's growth rate. In addition, the growing number of research and development activities over the life sciences and the presence of supportive government proposals and regenerative medicine research is further expected to favor the cell expansion market growth.
Growing incidence of cancer results in a huge patient count, creating an opportunity for the manufacturers to focus more on the R&D. In countries like India, Brazil, and China, biotechnology and pharmaceutical companies have grown prominently and are projected to accelerate the demand for cell expansion for research and development activities and pharma products production.
MARKET RESTRAINTS:
The constraints faced by the growth of the cell expansion market include the requirement of a skilled workforce and high-tech instrumentation. However, despite these constraints, the market clocks a robust CAGR of more than 18% and is set to expand further based on its diverse driving factors.
Impact of COVID-19 on the global cell expansion market:
The World Health Organization (WHO) declared the COVID 19 pandemic as an emerging health issue and has affected millions of lives, including the business sectors. The sudden outburst of COVID 19 has positively influenced the cell expansion market. Different cell expansion products are like cell culture media, and instruments are used in COVID 19 research. Regenerative medicine and stem cell research are one of the significant applications of cell expansion.
Cell-based strategies, mainly using mesenchymal stromal cells (MSCs), provide a promising approach to justifying the COVID 19 infection's side effects. MSCs are a promising tool used for treating diseases, including immune dysregulation and broad tissue damage, with COVID 19 and multiple clinical trials were launched. With the COVID 19, stem cell therapies and particularly mesenchymal stem cell (MSC) appropriate therapies have exhibited therapeutic potentiality, especially for newly existing diseases with no available treatments.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By Product, Cell Type, Application, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This research report on the global cell expansion market has been segmented and sub-segmented into the following categories.
Cell Expansion Market - By Product:
The consumables segment is forecasted to lead the global cell expansion market during the forecast period based on the product. The mounting production for vaccines and other biologics in the biopharmaceutical and biotechnology industries aid in segment growth.
The instruments segment is registered to have a quick CAGR growth rate during the forecast period—the automated platforms' approach standardizing the process and advances process tracking while decreasing hands-on time. These factors heighten the cell expansion market growth globally.
The disposables segment is predicted to record a quick growth rate during the historical period. The insignificant threat is relevant to cross-contamination of the laboratory's equipment and the blooming pharmaceutical and biotechnology industry booming the cell expansion market growth.
Cell Expansion Market - By Cell Type:
The human cells segment to have the largest share in the market over the historical period. However, the segment growth depends on rising investments made by the public and private organizations for research and development on human cells, intensifying human stem cell application areas, and escalating diseases like cancer.
Human stem cells gained superior resistance and were expected to observe the quickest CAGR rate from 2020 to 2025. In addition, the execution of automated, robotic, and closed production systems boost the market growth globally.
Cell Expansion Market - By Application:
The regenerative medicine application segment is to dominate the cell expansion market globally. For instance, cellular-based therapies have attained colossal popularity over regenerative medicine with stable improvements in injectable cell delivery systems for different clinical applications.
Cell Expansion Market - By End User:
The biotech and pharma companies have the largest share in the global cell expansion market based on the end-user. The segment growth is due to increasing consciousness about advanced treatments like personalized and other cell-based therapies. The pharma and biopharma companies are involved in acquisitions in enlarging their production portfolio. For example, in December 2019, Sartorius AG agreed to obtain 50% of Biological Industries' shares. The purchase outstretched the cell culture media portfolio of Sartorius, particularly for cellular and gene therapies, regenerative medicine, and other developed therapies.
Cell Expansion Market - By Region:
As of 2020, North America leads the market, accounting for a significant stake in the global market share. North America’s lead is warranted by the presence of key market players in the region, a relatively high number of registered treatments, and the increasing use of cartilage repair or regeneration to treat sports injuries and other accidents. Europe comes in second in terms of market share due to rising awareness about blood-related disorders and the swift availability of treatment in terms of plasma fractionation. However, Asia-Pacific is expected to outpace all other regions by clocking the highest CAGR during the forecast period, majorly because of a vast population base and companies looking to tap the region's market potential.
KEY MARKET PARTICIPANTS:
Some of the prominent companies leading the cell expansion market profiled in the report include Beckman Coulter, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
RECENT MARKET DEVELOPMENTS:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.2.1 Reagents. Media & Serum
5.1.3 Instruments
5.1.3.1 Cell Expansion Supporting Equipment
5.1.3.2 Bioreactors
5.1.3.3 Automated Cell Expansion Systems
5.1.4 Disposables
5.1.4.1 Tissue Culture Flasks
5.1.4.2 Bioreactor Accessories
5.1.4.3 Other Disposables
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Cell Type
5.2.1 Introduction
5.2.2 Human Cells
5.2.2.1 Stem Cells
5.2.2.2 Differenciated Stem Cells
5.2.3 Animal Cells
5.2.4 Y-o-Y Growth Analysis, By Cell Type
5.2.5 Market Attractiveness Analysis, By Cell Type
5.2.6 Market Share Analysis, By Cell Type
5.3 Application
5.3.1 Introduction
5.3.2 Regenerative Medicine & Stem Cell Research
5.3.3 Cancer and Cell-Based Research
5.3.4 Other Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Biotechnology & Pharmaceutical Companies
5.4.4 Academic Institutes & Research Facilities
5.4.5 Y-o-Y Growth Analysis, By End User
5.4.6 Market Attractiveness Analysis, By End User
5.4.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Cell Type
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Cell Type
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Cell Type
6.1.5.4 By Application
6.1.5.5 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Beckman Coulter
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Becton, Dickinson and Company
8.3 Corning
8.4 GE Healthcare
8.5 Lonza
8.6 Merck KGaA
8.7 Miltenyi Biotec
8.8 STEMCELL Technologies
8.9 Terumo BCT
8.10 Thermo Fisher Scientific
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
